1. Home
  2. DSWL vs IFRX Comparison

DSWL vs IFRX Comparison

Compare DSWL & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSWL
  • IFRX
  • Stock Information
  • Founded
  • DSWL 1987
  • IFRX 2007
  • Country
  • DSWL Macau
  • IFRX Germany
  • Employees
  • DSWL N/A
  • IFRX N/A
  • Industry
  • DSWL Plastic Products
  • IFRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DSWL Industrials
  • IFRX Health Care
  • Exchange
  • DSWL Nasdaq
  • IFRX Nasdaq
  • Market Cap
  • DSWL 64.1M
  • IFRX 53.5M
  • IPO Year
  • DSWL 1995
  • IFRX 2017
  • Fundamental
  • Price
  • DSWL $3.96
  • IFRX $1.18
  • Analyst Decision
  • DSWL
  • IFRX Strong Buy
  • Analyst Count
  • DSWL 0
  • IFRX 5
  • Target Price
  • DSWL N/A
  • IFRX $7.40
  • AVG Volume (30 Days)
  • DSWL 43.6K
  • IFRX 1.0M
  • Earning Date
  • DSWL 11-14-2025
  • IFRX 11-07-2025
  • Dividend Yield
  • DSWL 5.03%
  • IFRX N/A
  • EPS Growth
  • DSWL 45.62
  • IFRX N/A
  • EPS
  • DSWL 0.70
  • IFRX N/A
  • Revenue
  • DSWL $67,610,000.00
  • IFRX $191,224.00
  • Revenue This Year
  • DSWL N/A
  • IFRX N/A
  • Revenue Next Year
  • DSWL N/A
  • IFRX $1,216.24
  • P/E Ratio
  • DSWL $5.56
  • IFRX N/A
  • Revenue Growth
  • DSWL N/A
  • IFRX 54.36
  • 52 Week Low
  • DSWL $1.93
  • IFRX $0.71
  • 52 Week High
  • DSWL $4.48
  • IFRX $2.82
  • Technical
  • Relative Strength Index (RSI)
  • DSWL 56.57
  • IFRX 47.44
  • Support Level
  • DSWL $3.80
  • IFRX $1.09
  • Resistance Level
  • DSWL $4.40
  • IFRX $1.77
  • Average True Range (ATR)
  • DSWL 0.21
  • IFRX 0.21
  • MACD
  • DSWL -0.05
  • IFRX -0.05
  • Stochastic Oscillator
  • DSWL 28.77
  • IFRX 24.26

About DSWL Deswell Industries Inc.

Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: